Tunch Akmandor, Clinical Intern and PhD in Cancer Immunotherapy at Istanbul University-Cerrahpasa, shared a post on LinkedIn:
“How robust is your clinical governance in real-time skincancer surgery (aka Mohs Micrographic Surgery)?
Pleased to present our work at the Royal College of Physicians Medicine 2026 Conference in London through both a poster and rapid oral presentation:
‘Closed-Loop Quality Assurance in Mohs Micrographic Surgery: Longitudinal Diagnostic Concordance and Documentation Governance (2021-2025)’
Conducted at our specialist MMS center at University College London Hospitals NHS Foundation Trust with Dr. Sian Hughes and special thanks to Dr. Elizabeth Kulakov, Dr. Seshi Manam and Josh Christian.
This multi-cycle audit evaluated:
- Diagnostic concordance between intraoperative frozen sections and final histopathology
- Documentation governance within a specialist Mohs micrographic surgery pathway
- Longitudinal quality assurance across repeated audit cycles
Across 90 tumours assessed between 2021-2025, overall diagnostic concordance remained exceptionally high at 98.9%, with 100% concordance achieved in the 2025 cycle.
One of the key lessons from this project was that maintaining quality in specialist cancer surgery extends beyond technical diagnostic accuracy alone. Continuous audit, governance review, and documentation standards remain essential components of patient safety and service improvement.
Grateful to colleagues and collaborators involved in this ongoing quality assurance programme.”
Other articles featuring Tunch Akmandor on OncoDaily.
